Benaroya Research Institute
Benaroya Research Institute
Seattle, Washington, United States9 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Type 1 Diabetes Extension Study | Insulin Resistance, Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose intolerance, glucose metabolism disease, hyperglycemia, hyperinsulinism, immune system disorder, metabolic disease, type 1 diabetes mellitus | Recruiting | Not stated | 2026-09-18 | NCT02734277 | |
| CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Recruiting | Phase 1 / Phase 2 | 2026-09-11 | NCT06783309 | |
| Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Recruiting | Phase 2 | 2026-09-09 | NCT07216391 | |
| Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Recruiting | Phase 2 | 2026-09-08 | NCT07142252 | |
| Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D) | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Active, not recruiting | Phase 2 | 2026-09-02 | NCT05743244 | |
| Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Active, not recruiting | Phase 2 | 2026-09-01 | NCT03929601 | |
| Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics | Digestive System Diseases, Nutritional and Metabolic Diseases, acute pancreatitis, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, pancreas disorder, pancreatitis | Recruiting | Not stated | 2026-02-12 | NCT06401577 | |
| Diabetes RElated to Acute Pancreatitis and Its Mechanisms | Digestive System Diseases, Nutritional and Metabolic Diseases, acute pancreatitis, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, pancreas disorder, pancreatitis | Recruiting | Not stated | 2025-11-18 | NCT05197920 | |
| iMmune SignAtures and Clinical outComes in AP | Digestive System Diseases, acute pancreatitis, pancreas disorder, pancreatitis | Recruiting | Not stated | 2025-08-22 | NCT05878236 |